Table 2.

Preclinical and clinical trials testing mitochondria-targeted antioxidants in neurodegenerative diseases.

Neurodegenerative Diseases	MitoQ	MitoTEMPO	MitoVitE	SKQ1
Parkinson’s disease (PD)	[81,82,83,84,85,86,87,88]	[89,90,91,92]	[88,92]	[83,92]
Alzheimer’s disease (AD)	[76,88,93,94,95,96,97]	[76,92,95,98,99]	[76,88,92,95]	[92,100]
Huntington’s disease (HD)	[56,88,101]	[76]	[88]
Amyotrophic lateral sclerosis (ALS)	[102,88]	[103]	[88]
Multiple Sclerosis	[104,105]	[106]		[107,108]